Cytochalasin D Promotes Osteogenic Differentiation of MC3T3-E1 Cells via p38-MAPK Signaling Pathway.
Bone defect caused by trauma, tumor resection, infection or congenital malformation is a common clinical disease. Bone tissue engineering is regarded as a promising way in bone defect reconstruction. Thus, agents that can promote osteogenesis have received great attention. Cytochalasin D (Cyto D), a metabolite derived from molds, proves to be able to modify actin and reorganize cytoskeleton. The purpose of this study is to explore the effect and mechanism of Cyto D on osteogenic differentiation of mouse pre-osteoblast MC3T3-E1 cells. Cyto D induced osteogenic differentiation of MC3T3-E1 cells was assessed by ALP staining, ARS, western blotting and RT-PCR, and specific pathway inhibitor was utilized to explore whether MAPK pathways were involved in this process. The results showed that the optimized concentration of action was 10-2μg/ml. The supplement of Cyto D could significantly up-regulate the expression of Runx2, OCN and OSX, enhance ALP activity, improve calcium deposition, and promote the phosphorylation level of p38 protein. Inhibition of the pathway significantly reduced the activation of p38, and expression of osteogenic-related genes. Cyto D can promote the osteogenic differentiation of MC3T3 cells via the p38-MAPK signaling pathway, but not the ERK1/2 or JNK, and it is a potential agent to improve osteogenesis.